Antineoplastons are bioactive chemical molecules that may be detected in urine as well as blood. These chemicals are built from peptides and amino acids. Antineoplastons, it is said, work to bolster the natural defenses that the body already possesses against cancer. On the other hand, there is not enough data to back up this hypothesis. Find out more about antineoplastons, including their potential drawbacks and advantages, in the following paragraphs.
Antineoplastons: Key Facts
The Food and Drug Administration (FDA) in the United States does not give its blessing for the use of antineoplastons in either the prevention or therapy of any condition. In the United States, the only way to get antineoplaston therapy is by participating in a clinical study at the clinic run by the drug’s creator. The claims that the medications are a “cure” for cancer and that any of them have been authorized by the FDA are false.
Why Do People Who Already Have Cancer Take It?
Antineoplaston treatment was initially developed by Dr. Burzynski in the 1970s. His views include that antineoplaston might have a role in the following situations:
- It offers some degree of protection against cancer.
- People who have cancer typically do not have adequate levels of antineoplastons, which are a component of the body’s natural defense system.
There is a lack of sufficient proof in the scientific community about antineoplaston treatment. Researchers are unable to conclude that it is effective as an alternate treatment for cancer.
The Adverse Effects of Antineoplastons
During clinical tests, it was discovered that antineoplastons caused a few unwanted side effects, including the following:
- irregular heartbeat
- low numbers of red blood cells (anemia)
- high blood pressure
- loss of appetite
- swelling, pain, or stiffness in the joints
- abnormal calcium levels in the blood
- swelling near the brain
- skin rashes
- a high temperature (fever)
- fits (seizures)
Keep in mind that it is absolutely necessary to discuss any alternative treatments for cancer with your specialist before beginning any of those treatments. Particularly so in the event that you are undergoing further therapies for your malignancy.